PRIMR

PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

Re**al spacers and fiducial markers can help make prostate radiation safer and more precise.In this blog, we explain wha...
09/08/2026

Re**al spacers and fiducial markers can help make prostate radiation safer and more precise.

In this blog, we explain what they do and what patients can expect from the procedure.

https://www.primrmed.com/

Unlock stronger trial outcomes with PRIMR’s patient-centered videos.Simple, engaging content that helps patients decide ...
09/03/2026

Unlock stronger trial outcomes with PRIMR’s patient-centered videos.

Simple, engaging content that helps patients decide with confidence. 📊✅

www.primrmed.com

09/02/2026

▶️ Testing your tumor or blood can reveal whether an EGFR mutation is driving the cancer and which specific type you have.

Because different EGFR mutations behave differently, the results help your doctor choose treatments that specifically target EGFR-mutant cells. This makes your treatment plan more precise and personalized.

Learn more:
https://www.primrmed.com/cancer-education/what-is-egfr-positive-lung-cancer

PRIMR delivers predictive intelligence that keeps sponsors ahead of patient and site engagement trends in trials. 🔮🏥http...
09/01/2026

PRIMR delivers predictive intelligence that keeps sponsors ahead of patient and site engagement trends in trials. 🔮🏥

https://www.primrmed.com/

08/31/2026

🎯 This Alliance for Clinical Trials in Oncology study is testing whether Lu‑177 dotatate can work better than everolimus for advanced lung NETs. It delivers targeted radiation to cancer cells and may help shrink or control tumors, with the goal of improving outcomes or causing fewer side effects than current treatment.

Learn more. Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/alliance-lung-nets

breaks down complex trial info visually.

breaks down complex trial info visually.The Alliance for Clinical Trials in Oncology Lung NETs Study tests whether Lu‑...
08/31/2026

breaks down complex trial info visually.

The Alliance for Clinical Trials in Oncology Lung NETs Study tests whether Lu‑177 dotatate can outperform everolimus—the only approved option, which can fail or cause side effects—for better control of advanced lung NETs.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/alliance-lung-nets

PRIMR’s video resources make clinical trials easier to understand and join. Empower patients with clear, trusted informa...
08/27/2026

PRIMR’s video resources make clinical trials easier to understand and join. Empower patients with clear, trusted information that builds confidence. 🎥💡

https://www.primrmed.com/

Address

Hartford, CT
06117

Website

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category